Loading...
XSTOADDV B
Market cap60mUSD
Dec 23, Last price  
3.48SEK
1D
5.78%
1Q
-47.03%
Jan 2017
83.16%
Name

ADDvise Group AB (publ)

Chart & Performance

D1W1MN
XSTO:ADDV B chart
P/E
6.43
P/S
0.48
EPS
0.54
Div Yield, %
0.00%
Shrs. gr., 5y
33.98%
Rev. gr., 5y
38.62%
Revenues
1.37b
+44.30%
33,350,00034,343,000022,289,00050,466,000100,366,000120,032,000138,068,000146,578,000195,288,000239,914,000268,219,000349,877,000358,487,000465,953,000951,521,0001,373,000,000
Net income
104m
+27.62%
1,101,000-971,0000-4,771,000-275,000-3,595,000-4,566,000-4,761,000-11,098,000372,000-5,813,000-1,070,0004,059,00014,638,0002,805,00081,100,000103,500,000
CFO
175m
+59.27%
1,412,000307,000-2,598,0001,129,0007,413,000-6,188,000-8,599,000-3,773,000-33,340,000-18,741,00060,00011,187,00057,438,00010,186,000109,876,000175,000,000
Dividend
Apr 26, 20210.02 SEK/sh
Earnings
Feb 20, 2025

Profile

ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The company's Lab business unit designs, manufactures, and sells clean room systems and safety ventilation to laboratories, and scales to the research, industrial and grocery sectors. It is also involved in sale of equipment to laboratories, including centrifuges, water baths, and environmental chambers, and service and maintenance of scales, laboratory equipment, and storage of products. Its Healthcare business unit engages in the design, manufacture, and sale of the surgical tables, healthcare, and safety products, medtech cables, connection systems, orthopedic implants, stents for foot and ankle surgery, equipment, and software for monitoring patients, as well as operates online pharmacy. This segment also offers sale of consumable materials for healthcare, ultrasound systems, radiographic equipment, and examination tables for urology and gynecology. In addition, the company supplies laboratory furnishings and apparatus. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.
IPO date
Mar 01, 1998
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,373,000
44.30%
951,521
104.21%
465,953
29.98%
Cost of revenue
479,500
559,256
299,705
Unusual Expense (Income)
NOPBT
893,500
392,265
166,248
NOPBT Margin
65.08%
41.23%
35.68%
Operating Taxes
60,800
26,888
4,853
Tax Rate
6.80%
6.85%
2.92%
NOPAT
832,700
365,377
161,395
Net income
103,500
27.62%
81,100
2,791.27%
2,805
-80.84%
Dividends
(2,794)
Dividend yield
0.22%
Proceeds from repurchase of equity
100,000
100,000
152,811
BB yield
-3.95%
-7.62%
-12.13%
Debt
Debt current
90,000
33,544
29,044
Long-term debt
1,614,500
820,983
561,645
Deferred revenue
300
449
Other long-term liabilities
288,700
227,143
108,024
Net debt
1,318,000
728,721
250,603
Cash flow
Cash from operating activities
175,000
109,876
10,186
CAPEX
(9,200)
(13,962)
(4,137)
Cash from investing activities
(684,900)
(638,587)
(201,662)
Cash from financing activities
783,500
303,018
473,975
FCF
831,526
313,814
57,388
Balance
Cash
386,500
111,093
325,735
Long term investments
14,713
14,351
Excess cash
317,850
78,230
316,788
Stockholders' equity
201,600
175,884
24,169
Invested Capital
2,314,000
1,393,975
875,522
ROIC
44.91%
32.20%
28.03%
ROCE
33.29%
24.88%
18.18%
EV
Common stock shares outstanding
185,803
177,457
143,134
Price
13.64
84.32%
7.40
-15.91%
8.80
587.50%
Market cap
2,534,349
92.99%
1,313,183
4.26%
1,259,577
769.81%
EV
3,852,349
2,041,904
1,510,180
EBITDA
1,002,200
420,197
176,981
EV/EBITDA
3.84
4.86
8.53
Interest
153,700
45,724
37,423
Interest/NOPBT
17.20%
11.66%
22.51%